March 9 (Reuters) - Valeant Pharmaceuticals International Inc (NYSE:VRX) VRX.TO :
* Announces the addition of three new independent directors to its board
* Says Valeant has increased the size of its board to 14 members, 12 of whom
are independent
* Says Anders Lonner has stepped down as a director due to other priorities and
personal commitments
* Fred Eshelman, Stephen Fraidin and Thomas W. Ross, Sr. have joined its board
of directors
* Stephen Fraidin is currently vice chairman at pershing square capital
management L.P.
* Source text for Eikon ID:nPn3slqQp
* Further company coverage VRX.TO